Mechanism of action of contraceptive synthetic progestins.
D013734:Androgen-Insensitivity Syndrome / Q000097:blood; D000818:Animals; D005260:Female; D005640:Follicle Stimulating Hormone / Q000037:antagonists & inhibitors* / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000037:antagonists & inhibitors* / Q000097:blood; D008297:Male; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000494:pharmacology; D017258:Medroxyprogesterone Acetate; D008593:Menopause; D009640:Norethindrone / Q000031:analogs & derivatives* / Q000494:pharmacology; D010053:Ovary / Q000502:physiology; D011817:Rabbits; D051381:Rats; D011987:Receptors, Steroid / Q000378:metabolism; D012756:Sheep
D011987:Receptors, Steroid; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone; C024319:norethindrone enanthate; D009640:Norethindrone